“It’s not like something is going to happen because I believe in it. Sometimes you end up worse off because you believed in something too much. There are times
$SILO has finalized an agreement to sublicense the technology covered by its recently announced provisional #patent applications filed with the @uspto. The patent pertains to Silo Pharma’s #novel & #proprietary central nervous system (CNS) homing peptides
https://t.co/i7Dt2tGioa
According to long time investor Marc Davis Xphyto Therapeutics could be targeting Lufthansa as well as major European airports and pharmacies with their newly approved Covid-ID Lab test kit: https://t.co/YkI9lfDc89 $XPHY $XPHYF